??-Retinoic_Acid

Category

??-Retinoic_Acid




Useful info

??-Retinoic_Acid Brand names, ??-Retinoic_Acid Analogs

??-Retinoic_Acid Brand Names Mixture

  • No information avaliable
  • ??-Retinoic_Acid Chemical_Formula

    C20H28O2

    ??-Retinoic_Acid RX_link

    http://www.rxlist.com/cgi/generic/tretinoin.htm

    ??-Retinoic_Acid fda sheet

    ??-Retinoic_Acid FDA

    ??-Retinoic_Acid msds (material safety sheet)

    ??-Retinoic_Acid MSDS

    ??-Retinoic_Acid Synthesis Reference

    Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)

    ??-Retinoic_Acid Molecular Weight

    300.435 g/mol

    ??-Retinoic_Acid Melting Point

    181 oC

    ??-Retinoic_Acid H2O Solubility

    <0.1 g/100 mL

    ??-Retinoic_Acid State

    Solid

    ??-Retinoic_Acid LogP

    5.067

    ??-Retinoic_Acid Dosage Forms

    Capsule; Cream; Gel; Liquid

    ??-Retinoic_Acid Indication

    For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

    ??-Retinoic_Acid Pharmacology

    Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).

    ??-Retinoic_Acid Absorption

    1-31% (topical);

    ??-Retinoic_Acid Toxicity

    No information avaliable

    ??-Retinoic_Acid Patient Information

    No information avaliable

    ??-Retinoic_Acid Organisms Affected

    Humans and other mammals